Why Science? | Bacteriophages, Host Range and Phage-Therapy Evidence

Section 1 of 36

1. Bacteriophages are viruses of bacteria

A bacteriophage, or phage, is a virus that infects bacteria. A phage particle may carry genetic material inside a protein structure and use molecular interactions to attach to a suitable bacterial host.

“Virus of bacteria” is a useful start, not a promise that every phage infects every bacterium. Host range, bacterial state and environment shape what happens next.

Contents · Next section

Section 2 of 36

2. Attachment begins with recognition

Phage structures bind to receptors on a bacterial surface. Receptors can include proteins, sugars or other cell-envelope features. If the required receptor is absent, altered or hidden, infection may fail.

This first contact explains part of host specificity. It also shows why a bacterial species name alone may not predict whether a particular phage will work against a particular strain.

Contents · Previous section · Next section

Section 3 of 36

3. Entry delivers genetic instructions

After attachment, many phages inject or otherwise deliver their genetic material into the bacterium. The protective capsid may remain outside while the genome enters. Other phage types use different mechanisms.

The genome then interacts with bacterial machinery and defence systems. A diagram should separate what is directly observed from a simplified life-cycle model.

Contents · Previous section · Next section

Section 4 of 36

4. Lytic infection makes new particles

In a lytic cycle, phage genes direct production of components, new particles assemble and the host cell eventually lyses, releasing progeny. Timing and yield vary with phage, host and conditions.

Lysis is not the same as a disinfectant dissolving cells on contact. It is a biological infection process with stages, probabilities and evolutionary consequences.

Contents · Previous section · Next section

Section 5 of 36

5. Temperate phages can take another route

Some phages can integrate genetic material into a host genome or persist in another non-lytic state before later entering lytic growth. Such temperate behaviour matters for ecology, bacterial traits and therapeutic selection.

A therapy candidate is therefore characterised beyond “kills bacteria once.” Genome analysis and laboratory testing help identify undesirable genes or life-cycle features.

Contents · Previous section · Next section

Section 6 of 36

6. Bacteria possess defence systems

Bacteria can block adsorption, modify receptors, cut foreign genetic material, use CRISPR-associated immunity or trigger other defences. Phages, in turn, evolve countermeasures.

This moving relationship is an example of coevolution. Resistance is not evidence that evolution stopped; it is evidence that selection continues on both sides.

Contents · Previous section · Next section

Section 7 of 36

7. Did You Know? Phages are part of ordinary microbial ecosystems

Phages occur wherever bacteria live, including water, soil and bodies. They influence bacterial abundance, gene movement and nutrient cycles. Their ecological importance is larger than the therapeutic story alone.

That abundance does not make environmental collection safe or a phage medically usable. Research isolation, purification and characterisation belong in appropriately equipped laboratories.

Contents · Previous section · Next section

Section 8 of 36

8. Host range is an experimental result

Host range describes which tested bacterial strains a phage can infect under specified conditions. It may be narrow or broader, and it can depend on the assay.

Do not convert “infected five laboratory strains” into “kills this species everywhere.” The tested panel, bacterial identity and method determine the boundary of the claim.

Contents · Previous section · Next section

Section 9 of 36

9. A clear zone can have several causes

On a bacterial lawn, plaques may appear where phage infection reduced growth. Plaque number and appearance can support analysis, but clearing can also be influenced by high particle concentrations, enzymes or bacterial physiology.

Follow-up assays help distinguish productive infection from a one-time inhibition effect. A photograph of a clear spot is not complete host-range evidence.

Researchers may pick an isolated plaque, amplify the candidate under controlled conditions and repeat testing with fresh bacterial cultures. They can compare plaque formation across dilutions and inspect whether new infectious particles were produced. This sequence matters because a clear patch created by “lysis from without” at very high particle numbers would not demonstrate the same replicating infection as well-separated plaques that remain countable through serial dilution.

Contents · Previous section · Next section

Section 10 of 36

10. Efficiency of plating compares outcomes

Researchers may compare plaque formation on a test host with a reference host. The resulting ratio can help describe relative infectivity under the assay conditions.

Small counts have large uncertainty, and zero plaques may reflect detection limits. Report replicate plates, dilution, counting rules and the reference denominator.

Contents · Previous section · Next section

Section 11 of 36

11. Multiplicity of infection is a ratio, not a guarantee

Multiplicity of infection compares phage particles added with bacterial cells present. It is often an average, so individual cells do not each receive exactly the same number of particles.

Adsorption, particle viability and spatial mixing affect actual encounters. “MOI of one” does not mean one successful phage per bacterium.

Contents · Previous section · Next section

Section 12 of 36

12. One-step growth experiments reveal timing

A one-step growth experiment can estimate an eclipse or latent period and burst size under defined conditions. Researchers synchronise infection approximately, remove or dilute free particles and sample over time.

The curve describes that phage–host pair in that medium and temperature. It is not a universal biological constant.

Contents · Previous section · Next section

Section 13 of 36

13. Genome sequencing checks identity and risk

Sequencing can confirm phage identity, reveal relatedness and screen for genes associated with lysogeny, toxins or antimicrobial resistance. Annotation still contains uncertainty, especially for genes with unknown functions.

“No harmful gene detected” means none was found with the methods and databases used. It does not prove every unknown sequence is harmless.

Contents · Previous section · Next section

Section 14 of 36

14. Purity includes more than phage concentration

A preparation can contain bacterial debris, endotoxin, residual media, host DNA or other contaminants. Purification and quality testing matter before clinical or research use.

Counting infectious particles answers one question. It does not certify identity, sterility, purity or suitability for a person.

Contents · Previous section · Next section

Section 15 of 36

15. Matching begins with the patient isolate

Personalised phage work may test candidates against bacteria isolated from a patient. The process requires accurate bacterial identification and a suitable panel of characterised phages.

Time matters in serious infection, so matching must fit within clinical care. This is not a home susceptibility test; it sits inside specialist microbiology and medical decision-making.

Contents · Previous section · Next section

Section 16 of 36

16. Cocktails combine several phages

A phage cocktail may broaden host coverage or reduce the chance that one resistance mechanism defeats the entire treatment. Components can also interact, compete or vary in stability.

More phages are not automatically better. Each component needs identity, activity, compatibility and quality evidence.

Contents · Previous section · Next section

Section 17 of 36

17. Resistance can bring trade-offs

Bacteria that evolve phage resistance may alter receptors or other systems. In some cases, those changes can affect virulence, fitness or antibiotic sensitivity. In other cases, resistance may carry little useful cost.

Claims about beneficial trade-offs require data for the specific host, phage and environment. Evolution is an opportunity to study, not a guaranteed treatment trick.

Contents · Previous section · Next section

Section 18 of 36

18. Antibiotics and phages can interact

Some experiments study phage–antibiotic combinations. Effects may be synergistic, additive, neutral or antagonistic, depending on timing, concentration and biology.

NIH’s research programme explicitly asks whether phages might complement or replace antibiotics in some contexts. “Might” marks an open scientific question, not a public instruction to change medication.

Contents · Previous section · Next section

Section 19 of 36

19. Worked example: host range needs a panel

These invented data are for reasoning practice only and do not identify a treatment candidate.

A responsible report includes replicate variation, bacterial identity, dilution and assay conditions before classifying host range.

Contents · Previous section · Next section

Section 20 of 36

20. Dose requires active-particle measurement

Phage preparations may be described in plaque-forming units, a biological measure of infectious activity under an assay. Physical particle counts can be higher because not every particle forms a plaque.

Dose, route, timing and distribution affect exposure at the infection site. An impressive vial concentration does not reveal what reaches bacteria in the body.

Pharmacokinetic measurements can track how phage levels change in blood or other sampled compartments, while pharmacodynamic measurements ask how the bacterial population responds. Both depend on sampling time. A concentration measured soon after dosing and one measured a day later answer different questions. Clear timelines prevent a transient peak from being mistaken for sustained exposure.

Contents · Previous section · Next section

Section 21 of 36

21. The immune system can change exposure

The body may clear phages, generate antibodies or respond to components of a preparation. Delivery route and repeated dosing influence these interactions.

Therapeutic design therefore connects microbiology with pharmacology and immunology. Killing bacteria in a dish is not the same as treating an infection safely.

Contents · Previous section · Next section

Section 22 of 36

22. Clinical trials separate promise from inference

An early-stage trial may focus mainly on safety, tolerability and signals that bacteria are reduced. Later studies may compare clinical outcomes across larger groups.

NIH’s supported cystic-fibrosis trial was designed to evaluate safety and whether phage therapy could reduce Pseudomonas aeruginosa in participants’ lungs. That careful wording should replace claims that a cure was already proven.

Contents · Previous section · Next section

Section 23 of 36

23. Controls are difficult but essential

Clinical studies need comparison groups, randomisation or blinding where appropriate, predefined outcomes and transparent analysis. Personalised phage matching can make standard designs harder, but it does not make controls unnecessary.

Case reports can reveal possibility and guide research. They cannot estimate average effectiveness on their own.

Outcomes also need definitions. Reduced bacterial counts, improved lung function, shorter hospital stay and survival are not interchangeable endpoints. A study can show movement in one without proving all the others. Pre-registering outcomes and analysis plans makes it harder to select only the most flattering signal after data are seen. Trials should report adverse events and missing data alongside any benefit.

Contents · Previous section · Next section

Section 24 of 36

24. Regulation protects identity and quality

Therapeutic phages are biological products whose production and use involve regulatory oversight. Identity, purity, potency, sterility, manufacturing consistency and clinical protocol matter.

Changes during production deserve comparability evidence. Moving to another bacterial host, purification method, container or storage condition can alter the final preparation even if the phage name stays the same. Batch records and release tests connect the administered material to the characterised candidate. This discipline protects patients and also protects the scientific interpretation of a trial.

FDA and NIAID materials emphasise that each phage–bacterial-host pair is unique. Regulation is not separate from the science; it asks whether the evidence chain survives real use.

Contents · Previous section · Next section

Section 25 of 36

25. Primary Science can explore specificity with models

Young learners can match paper “phage keys” to drawn “bacterial locks” and then identify where the analogy breaks. They can learn that classification and fit depend on features.

Do not culture environmental bacteria or collect biological samples. Safe modelling can teach specificity without exposure.

Contents · Previous section · Next section

Section 26 of 36

26. PSLE Science practice: avoid absolute words

A PSLE-style item can show invented clearing zones across four bacterial types. A strong answer says which type showed evidence of susceptibility under the test conditions. It avoids “the phage kills all bacteria.”

Science tuition helps when it teaches condition, evidence and conclusion as a linked sentence.

Contents · Previous section · Next section

Section 27 of 36

27. Secondary Biology connects infection and evolution

Students can link cells, viruses, DNA, mutation, selection and ecosystems. Phage resistance gives a concrete example of variation and changing frequency under selection.

The context also distinguishes antibiotics, which act on bacteria through chemical mechanisms, from phages, which infect bacteria biologically.

Contents · Previous section · Next section

Section 28 of 36

28. O-Level learning needs syllabus boundaries

The current Singapore–Cambridge O-Level Biology syllabus supplies foundations in microorganisms, genetics, immunity and experimental skills. Detailed phage therapy is an extension, not a guaranteed examination requirement.

Use the topic to practise unfamiliar-data interpretation while following current school guidance for assessed content.

Contents · Previous section · Next section

Section 29 of 36

29. Mathematics makes uncertainty visible

Serial dilutions, plaque counts, ratios, growth curves and confidence intervals support phage research. Logarithmic scales help display wide concentration ranges. A zero on a plate may represent a detection limit rather than mathematical zero.

Always preserve units and denominators. A dramatic percentage without starting counts can mislead.

Contents · Previous section · Next section

Section 30 of 36

30. Computing helps compare genomes

Bioinformatics assembles sequences, compares related phages and screens for known genes. Databases evolve, so automated annotations need versioning and expert review.

A colourful genome map is a hypothesis-rich representation. Laboratory evidence still tests infection, host range and quality.

Contents · Previous section · Next section

Section 31 of 36

31. Ecology broadens the story

Phages can influence microbial food webs, population turnover and gene exchange. In oceans and soils, bacterial lysis releases material used by other organisms.

Therapy uses one part of a much wider ecology. Understanding that context guards against describing phages only as tiny medicines.

Contents · Previous section · Next section

Section 32 of 36

32. Public-health communication must stay calm

Antibiotic resistance creates serious need for new tools, but urgency should not erase uncertainty. Avoid “miracle cure,” “natural means safe” and “antibiotics are obsolete.”

Good communication names the infection, phage, evidence stage, comparator, outcome and safety findings.

Contents · Previous section · Next section

Section 33 of 36

33. Questions for science tuition and enrichment

Ask whether Primary Science tuition, PSLE Science tuition, Secondary Science tuition or STEM enrichment teaches host specificity, fair tests and cautious conclusions. A safe activity uses diagrams or authorised datasets, never home culture.

Students should leave able to explain why one clear plaque is exciting evidence and still not a treatment verdict.

Contents · Previous section · Next section

Section 34 of 36

34. Questions for school choices

Families can ask how schools teach microbiology safety, evolution, data analysis and ethics. Verify current facilities and programmes through official sources rather than assuming access to phage laboratories.

Strong Science education can teach the reasoning with models, public data and well-designed discussions.

Contents · Previous section · Next section

Section 35 of 36

35. Career pathways without promises

Phage research connects microbiologists, clinicians, pharmacists, genomic scientists, process engineers, laboratory technologists, statisticians, quality specialists and regulators. Students build options through Biology, Chemistry, Mathematics, computing, safety and communication.

No article promises admission or employment. A useful portfolio task is a host-range evidence sheet that separates assay result, uncertainty and next test.

It can also include a one-page public explanation that defines host range, identifies the evidence stage and avoids promising a cure.

Contents · Previous section · Next section

Section 36 of 36

36. Final checklist: match before claiming

Identify the phage and bacterial strain; test productive infection across a defined panel; measure active particles; sequence and screen the genome; assess purity and contaminants; watch resistance; study combinations carefully; design clinical controls and outcomes; report safety and uncertainty; and keep treatment inside authorised medical and regulatory systems.

The visible fact-check anchors are the current NIH clinical-trial page and FDA–NIAID science-and-regulation materials, checked on 7 October 2026. The hopeful message is not that phages make medicine easy. It is that precise matching, careful trials and evolutionary thinking can open new, testable options.

Contents · Previous section · Continue to the Science Learning Hub